Cord Blood America's CEO Matthew Schissler, In Analyst Interview, Discusses China Expansion

LAS VEGAS, April 1 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ), is focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally.  Its CEO and co-founder, Matthew Schissler, in an interview with analyst Francis Gaskins, said its recent announcement to build the world's largest stem cell storage facility in China, in conjunction with AXM Pharma, Inc. (Pink Sheets: AXMP), makes great sense for three reasons:

• A higher percentage of Chinese are interested in storing stem cells than in populations in the U.S. and Europe.
• The barriers to entry into China are high and expensive.  By partnering with a Company which is already successful, and which holds key government licenses, Cord Blood America sees a pathway to success.
• China is the world's most populous country and Cord Blood America needs representation there to move forward with its worldwide growth strategy.

The entire interview is available at http://gaskinsco.com/cbai-3-31-10.mp3

The interview also features a discussion by Mr. Schissler of the Company's annual financial report, which was filed with the U.S. Securities & Exchange Commission this week.  "We now have a healthy balance sheet compared to where we were 12 months ago," CBAI's CEO said.  "The year 2010 will be dedicated to growing revenues."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

CONTACT:
Paul Knopick
E & E Communications
949/707-5365
[e-mail]

SOURCE Cord Blood America, Inc.

Copyright il 1 PR Newswire